Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Turner, Stephen T ^a   Schwartz, Gary L ^a   Chapman, Arlene B ^b   Beitelshees, Amber L ^c   Gums, John G ^d,e   Cooper DeHoff, Rhonda M ^d,e   Boerwinkle, Eric ^f   Johnson, Julie A ^d,e   Bailey, Kent R ^a  

^a MAYO CLINIC   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Antihypertensive drug therapy; Beta blocker; Blood pressure monitoring; Hypertension; Plasma renin activity; Thiazide diuretic

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; HYDROCHLOROTHIAZIDE;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG RESPONSE; FEMALE; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PREDICTION; SIGNAL NOISE RATIO; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; GENETICS; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SAMPLE SIZE; SIGNAL-TO-NOISE RATIO; TREATMENT OUTCOME;

EID: 84862825054     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-47     Document Type: Article

References (27)

1. Parati G, Omboni S, Bilo G. Why Is Out-of-Office Blood Pressure Measurement Needed? Home Blood Pressure Measurements Will Increasingly Replace Ambulatory Blood Pressure Monitoring in the Diagnosis and Management of Hypertension. Hypertension 2009, 54:181-187.
2. Appel LJ, Stason WB. Ambulatory blood pressure monitoring and blood pressure self-measurement in the diagnosis and management of hypertension. Ann Intern Med 1993, 118:867-882.
3. Mancia G, Parati G. Ambulatory blood pressure monitoring and organ damage. Hypertension 2000, 36:894-900.
4. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion JM. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004, 291:1342-1349. 10.1001/jama.291.11.1342, 15026401.
5. Staessen JA, Den Hond E, Celis H, Fagard R, Keary L, Vandenhoven G, O'Brien ET. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial. JAMA 2004, 291:955-964. 10.1001/jama.291.8.955, 14982911.
6. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators [see comments]. JAMA 1999, 282:539-546. 10.1001/jama.282.6.539, 10450715.
7. Mancia G, Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens 2004, 22:435-445.
8. Ishikawa J, Carroll DJ, Kuruvilla S, Schwartz JE, Pickering TG. Changes in home versus clinic blood pressure with antihypertensive treatments: a meta-analysis. Hypertension 2008, 52:856-864. 10.1161/HYPERTENSIONAHA.108.115600, 18809791.
9. Turner ST, Schwartz GL, Boerwinkle E. Personalized medicine for high blood pressure. Hypertension 2007, 50:1-5. 10.1161/HYPERTENSIONAHA.107.087049, 17470720.
10. Preston RA, Materson BJ, Reda DJ, Williams DW, Hamburger RJ, Cushman WC, Anderson RJ. Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. JAMA 1998, 280:1168-1172. 10.1001/jama.280.13.1168, 9777817.
11. Turner ST, Schwartz GL, Chapman AB, Beitelshees AL, Gums JG, Cooper-DeHoff RM, Boerwinkle E, Johnson JA, Bailey KR. Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension. Am J Hypertens 2010, 23:1014-1022. 10.1038/ajh.2010.98, 2941699, 20725057.
12. Chapman AB, Schwartz GL, Boerwinkle E, Turner ST. Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension. Kidney Int 2002, 61:1047-1055. 10.1046/j.1523-1755.2002.00200.x, 11849460.
13. Canzanello VJ, Baranco-Pryor E, Rahbari-Oskoui F, Schwartz GL, Boerwinkle E, Turner ST, Chapman AB. Predictors of blood pressure response to the angiotensin receptor blocker candesartan in essential hypertension. Am J Hypertens 2008, 21:61-66. 10.1038/ajh.2007.24, 18091745.
14. Finkielman JD, Schwartz GL, Chapman AB, Boerwinkle E, Turner ST. Reproducibility of blood pressure response to hydrochlorothiazide. J Clin Hypertens (Greenwich) 2002, 4:408-412.
15. Finkielman JD, Schwartz GL, Chapman AB, Boerwinkle E, Turner ST. Lack of agreement between office and ambulatory blood pressure responses to hydrochlorothiazide. Am J Hypertens 2005, 18:398-402. 10.1016/j.amjhyper.2004.10.021, 15797660.
16. Beitelshees AL, Gong Y, Bailey KR, Turner ST, Chapman AB, Schwartz GL, Gums JG, Boerwinkle E, Johnson JA. Comparison of office, ambulatory, and home blood pressure antihypertensive response to atenolol and hydrochlorthiazide. J Clin Hypertens (Greenwich) 2010, 12:14-21.
17. Johnson JA, Boerwinkle E, Zineh I, Chapman AB, Bailey K, Cooper-DeHoff RM, Gums J, Curry RW, Gong Y, Beitelshees AL, et al. Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study. Am Heart J 2009, 157:442-449. 10.1016/j.ahj.2008.11.018, 2671287, 19249413.
18. Topouchian JA, El Assaad MA, Orobinskaia LV, El Feghali RN, Asmar RG. Validation of two devices for self-measurement of brachial blood pressure according to the International Protocol of the European Society of Hypertension: the SEINEX SE-9400 and the Microlife BP 3AC1-1. Blood Press Monit 2005, 10:325-331. 10.1097/00126097-200512000-00008, 16330959.
19. O'Brien E, Mee F, Atkins N, O'Malley K. Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society protocol. J Hypertens 1991, 9:573-574. 10.1097/00004872-199106000-00016, 1653299.
20. Gill JS, Zezulka AV, Beevers DG, Davies P. Relation between initial blood pressure and its fall with treatment. Lancet 1985, 1:567-569.
21. Snedecor GW, Cochran WG. Statistical methods 1980, Ames IA,: Iowa State Univ. Press, 7.
22. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996, 273:1516-1517. 10.1126/science.273.5281.1516, 8801636.
23. Cannella G, Paoletti E, Barocci S, Massarino F, Delfino R, Ravera G, Di Maio G, Nocera A, Patrone P, Rolla D. Angiotensin-converting enzyme gene polymorphism and reversibility of uremic left ventricular hypertrophy following long-term antihypertensive therapy. Kidney Int 1998, 54:618-626. 10.1046/j.1523-1755.1998.00027.x, 9690230.
24. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, Glazer NL, Morrison AC, Johnson AD, Aspelund T, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet 2009, 41:677-687. 10.1038/ng.384, 2998712, 19430479.
25. Bell KJ, Hayen A, Macaskill P, Craig JC, Neal BC, Fox KM, Remme WJ, Asselbergs FW, van Gilst WH, Macmahon S, et al. Monitoring initial response to Angiotensin-converting enzyme inhibitor-based regimens: an individual patient data meta-analysis from randomized, placebo-controlled trials. Hypertension 2010, 56:533-539. 10.1161/HYPERTENSIONAHA.110.152421, 20625081.
26. Macrae CA, Vasan RS. Next-generation genome-wide association studies: time to focus on phenotype?. Circ Cardiovasc Genet 2011, 4:334-336. 10.1161/CIRCGENETICS.111.960765, 21846867.
27. Mokwe E, Ohmit SE, Nasser SA, Shafi T, Saunders E, Crook E, Dudley A, Flack JM. Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial. Hypertension 2004, 43:1202-1207. 10.1161/01.HYP.0000127924.67353.86, 15117912.